Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.
about
Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review)Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion eventsTacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.Highly malignant intra-hepatic metastatic hepatocellular carcinoma in rats.The Chinese Herb Jianpijiedu Contributes to the Regulation of OATP1B2 and ABCC2 in a Rat Model of Orthotopic Transplantation Liver Cancer Pretreated with Food Restriction and Diarrhea.Tacrolimus trough levels, rejection and renal impairment in liver transplantation: a systematic review and meta-analysis.Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.The Rho kinase inhibitor fasudil is involved in p53-mediated apoptosis in human hepatocellular carcinoma cells.Analogues of Y27632 increase gap junction communication and suppress the formation of transformed NIH3T3 coloniesRho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion.Activating ROCK1 somatic mutations in human cancer.Rho-kinase inhibitor targeting the liver prevents ischemia/reperfusion injury in the steatotic liver without major systemic adversity in rats.
P2860
Q28394917-4E1B5F48-B0F7-4E84-A80F-41A0405DBB37Q33629153-B44F673C-2531-4BFC-A772-748F452F936DQ33890996-B4F89D01-C10F-42C6-9E5C-6C3F9AD32BADQ34310280-5F7173EB-5B16-4BA6-93DC-95F523D1C8A0Q36333098-132B8D7C-2001-47E3-AA87-09677AA626F7Q38019054-6C215984-19D6-4156-94BF-E53426989D4EQ38972601-695D90DF-0581-43FB-9805-C81830E9D220Q39368544-679A2640-8AF4-4305-AC3E-395701B6275CQ39808155-C39A0CA4-BAA3-4D95-9208-5311A6E0E4B3Q39885550-4F34C256-1965-4472-BDCA-FD3C195FC6ABQ43169790-5F6D0656-6CF7-4B2A-818C-FB6CF98440A2Q55070697-8C0F0B5A-5385-47C2-B390-05C3E010E850
P2860
Rho-associated kinase inhibitor reduces tumor recurrence after liver transplantation in a rat hepatoma model.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Rho-associated kinase inhibito ...... ation in a rat hepatoma model.
@en
type
label
Rho-associated kinase inhibito ...... ation in a rat hepatoma model.
@en
prefLabel
Rho-associated kinase inhibito ...... ation in a rat hepatoma model.
@en
P2093
P2860
P1476
Rho-associated kinase inhibito ...... ation in a rat hepatoma model.
@en
P2093
Kobayashi T
Ushitora Y
P2860
P304
P356
10.1111/J.1600-6143.2006.01647.X
P407
P577
2007-01-04T00:00:00Z